儿童脓毒症标准:儿科脓毒症定义工作组系统综述与荟萃分析
16项研究(9629例)提供脓毒症/严重脓毒症/脓毒性休克结局数据,71项研究(154674例)提供死亡率结局数据。在感染儿童中,意识水平下降和较高的儿科死亡风险评分与脓毒症/严重脓毒症相关;在脓毒症/严重脓毒症/脓毒性休克患儿中,慢性病、肿瘤诊断、使用血管活性/正性肌力药物、机械通气、血清乳酸、血小板计数、纤维蛋白原、降钙素原、多器官功能障碍综合征、儿科 logistic 器官功能障碍评分、儿科死亡指数-3和儿科死亡风险评分均与死亡率显示显著且一致的关联。脓毒症、严重脓毒症和脓毒性休克患者的合并死亡率在高收入、中高收入和中低收入国家间存在差异(p < 0.0001)。
要点
- 在感染儿童中,意识水平下降和较高的儿科死亡风险评分与脓毒症/严重脓毒症相关。
- 在脓毒症/严重脓毒症/脓毒性休克患儿中,使用血管活性/正性肌力药物和机械通气均与死亡率显著且一致相关。
- 血清乳酸、血小板计数、纤维蛋白原、降钙素原、多器官功能障碍综合征、儿科 logistic 器官功能障碍评分、儿科死亡指数-3和儿科死亡风险评分均与脓毒症患儿死亡率显著且一致相关。
- 慢性病和肿瘤诊断与脓毒症患儿死亡率显著且一致相关。
- 脓毒症、严重脓毒症和脓毒性休克的合并死亡率在高收入、中高收入和中低收入国家间存在差异(p < 0.0001)。
适用人群与场景
- 胎龄≥37周至18岁、疑似或确诊感染的儿童,纳入病例对照研究、队列研究和随机对照试验。
- 研究场景未在原文中明确限定为急诊、ICU或院前。
诊断标准与关键阈值
- 原文未提及具体的诊断标准名称、评分界值或启动/停止阈值。
处置流程与药物剂量
- 原文未提及具体的处置流程或药物剂量方案。
红旗征与不能漏的情况
- 感染儿童出现意识水平下降与脓毒症/严重脓毒症相关。
- 脓毒症患儿出现多器官功能障碍综合征、需要血管活性/正性肌力药物或机械通气与死亡率显著相关。
研究设计与关键结果
- 在感染儿童中,意识水平下降和较高的儿科死亡风险评分与脓毒症/严重脓毒症相关。
- 在脓毒症/严重脓毒症/脓毒性休克患儿中,慢性病、肿瘤诊断、使用血管活性/正性肌力药物、机械通气、血清乳酸、血小板计数、纤维蛋白原、降钙素原、多器官功能障碍综合征、儿科 logistic 器官功能障碍评分、儿科死亡指数-3和儿科死亡风险评分均与死亡率显著且一致相关。
- 脓毒症、严重脓毒症和脓毒性休克的合并死亡率在高收入、中高收入和中低收入国家间存在差异(p < 0.0001)。
证据类型、等级与局限
- 证据类型:系统综述与荟萃分析(纳入病例对照研究、队列研究和随机对照试验)。
- 证据等级或推荐强度:原文未提及。
对床旁实践的改变
- 在感染儿童中应关注意识水平下降,因其与脓毒症/严重脓毒症相关。
- 在脓毒症患儿中,器官功能障碍标志物(如血清乳酸、血小板计数、纤维蛋白原、降钙素原、多器官功能障碍综合征、儿科 logistic 器官功能障碍评分等)与死亡率相关,可支持风险分层,但原文未给出具体阈值,不能作为决策阈值使用。
- 使用血管活性/正性肌力药物和机械通气与脓毒症患儿死亡率相关,提示需密切监测病情。
- 上述关联来自观察性研究和随机对照试验的汇总分析,不能推断因果关系或改变具体治疗措施。
指南或共识出处
- 原文未提及指南或共识名称;研究来自儿科脓毒症定义工作组(Pediatric Sepsis Definition Taskforce)。
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To determine the associations of demographic, clinical, laboratory, organ dysfunction, and illness severity variable values with: 1) sepsis, severe sepsis, or septic shock in children with infection and 2) multiple organ dysfunction or death in children with sepsis, severe sepsis, or septic shock.
DATA SOURCES: MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials were searched from January 1, 2004, and November 16, 2020.
STUDY SELECTION: Case-control studies, cohort studies, and randomized controlled trials in children greater than or equal to 37-week-old postconception to 18 years with suspected or confirmed infection, which included the terms "sepsis," "septicemia," or "septic shock" in the title or abstract.
DATA EXTRACTION: Study characteristics, patient demographics, clinical signs or interventions, laboratory values, organ dysfunction measures, and illness severity scores were extracted from eligible articles. Random-effects meta-analysis was performed.
DATA SYNTHESIS: One hundred and six studies met eligibility criteria of which 81 were included in the meta-analysis. Sixteen studies (9,629 patients) provided data for the sepsis, severe sepsis, or septic shock outcome and 71 studies (154,674 patients) for the mortality outcome. In children with infection, decreased level of consciousness and higher Pediatric Risk of Mortality scores were associated with sepsis/severe sepsis. In children with sepsis/severe sepsis/septic shock, chronic conditions, oncologic diagnosis, use of vasoactive/inotropic agents, mechanical ventilation, serum lactate, platelet count, fibrinogen, procalcitonin, multi-organ dysfunction syndrome, Pediatric Logistic Organ Dysfunction score, Pediatric Index of Mortality-3, and Pediatric Risk of Mortality score each demonstrated significant and consistent associations with mortality. Pooled mortality rates varied among high-, upper middle-, and lower middle-income countries for patients with sepsis, severe sepsis, and septic shock (p < 0.0001).
CONCLUSIONS: Strong associations of several markers of organ dysfunction with the outcomes of interest among infected and septic children support their inclusion in the data validation phase of the Pediatric Sepsis Definition Taskforce.
参考来源
- Menon K, Schlapbach LJ, Akech S, et al. Criteria for Pediatric Sepsis-A Systematic Review and Meta-Analysis by the Pediatric Sepsis Definition Taskforce. Crit Care Med. 2022. PMID: 34612847. doi:10.1097/CCM.0000000000005294
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。